SWOG clinical trial number
SWOG-9323 (E4592)

Laboratory/Clinical Correlative Studies in Non-Small Cell Lung Cancer: Ancillary Study to SWOG-9252 (INT-0115, E3590, RTOG-91-05, NCCTG 91-24-51)

Closed
Phase
Published
Abbreviated Title
Laboratory/Clinical Correlative Studies in Non-Small Cell Lung Cancer: Ancillary Study to SWOG-9252 (INT-0115, E3590, RTOG-91-05, NCCTG 91-24-51)
Activated
03/01/1994
Closed
12/01/1996

Research committees

Lung Cancer

Publication Information Expand/Collapse

2001

Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a lab ancillary study on an Eastern Cooperative Oncology Group prospective randomized trial of postop adjuvant therapy

JH Schiller;S Adak;RH Feins;SM Keller;WA Fry;RB Livingston;MEM Hammond;B Wolf;L Sabatini;J Jett;L Kohman;DH Johnson Journal of Clinical Oncology 19(2):448-457

1999

Prognostic significance of p53 and K-RAS mutations in primary resected non-small cell lung cancer: Preliminary results from a propsective randomized trial of postoperative adjuvant therapy (intergroup trial 0115).

JH Schiller;S Adak;R Feins;S Keller;W Fry;RB Livingston;B Wolf;J Jett;L Kohman;D Johnson;E Hammond Proc of the American Society of Clinical Oncology 18:464a(#1789)

Other Clinical Trials

SWOG Clinical Trial Number
CTSU/EA5231

A Randomized Phase III Trial of Checkpoint Blockade in Lung Cance3r Patients in the Adjuvant Setting Based on Pathologic Response Following Neoadjuvant Therapy (CLEAR)
Research Committee(s)
Lung Cancer
Activated
06/13/2025
Open
SWOG Clinical Trial Number
S2414

INcorporating pathologic reSponse in patIents with early staGe lung cancer to optimize immunotHerapy in the adjuvanT setting (INSIGHT)
Research Committee(s)
Lung Cancer
Symptom Control and Quality of Life
Activated
03/14/2025
Accrual
2%
Open
Phase
SWOG Clinical Trial Number
CTSU/A082304/S2402

Perioperative Versus Adjuvant Systemic Therapy In Patients with Resectable Non-Small Cell Lung Cancer - PROSPECT LUNG, CTIU2317
Research Committee(s)
Lung Cancer
Activated
12/11/2024
Open